Capsule Commentaries: Drug Reaction Considerations with Oral Minocycline

Main Article Content

James Q Del Rosso


drug-drug interaction, oral antibotic therapy, antibiotic, minocycline


Minocycline is a commonly prescribed oral antibiotic in dermatology with a favorable efficacy and safety profile, and with clinical applications for a variety of cutaneous infections and other skin disorders. Most patients do not experience any adverse events, although, rare but potentially serious side effects can emerge. In this article, drug hypersensitivity syndrome, hepatotoxicity, and pseudotumor cerebri associated with oral minocycline use are reviewed.


Del Rosso JQ, Webster GF, Rosen T, et al. Status report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society Part 1: antibiotic prescribing patterns, sources of antibiotic exposure, antibiotic consumption and emergence of antibiotic resistance, impact of alterations in antibiotic prescribing, and clinical sequelae of antibiotic use. J Clin Aesthet Dermatol. 2016;9(4):18–24.

Kim S, Michaels BD. Kim GK, Del Rosso JQ. Systemic antibacterial agents. In: Wolverton SE, Ed, Comprehensive Dermatologic Drug Therapy, 3rd Edition, Elsevier-Saunders, Philadelphia, Pennsylvania, 2013, pp 61-98.

Garrido-Mesa N, Zarzuelo A, Galvez J. Minocycline: far beyond an antibiotic. Br J Pharmacol. 2013;169(2):337-352.

VanEperen AS, Segreti J. Empirical therapy in methicillin-resistant Staphylococcus aureus infections: an up-to-date approach. J Infect Chemother. 2016;22(6):351-359.

van der Linden MMD, van Ratingen AR, van Rappard DC, et al. DOMINO, doxycycline 40 mg vs. minocycline 100 mg in the treatment of rosacea: a randomized, single-blinded, noninferiority trial, comparing efficacy and safety. Br J Dermatol. 2017;176(6):1465-1474.

Carris NW, Pardo J, Montero J, et al. Minocycline as a substitute for doxycycline in targeted scenarios: a systematic review. Open Forum Infect Dis. 2015 Nov 25;2(4):178. doi: 10.1093/ofid/ofv178. eCollection 2015 Dec.

Cummins DL, Delacerda D, Tausk FA. Mycobacterium marinum with different responses to second-generation tetracyclines. Int J Dermatol. 2005;44(6):518-520.

Leyden JJ, Del Rosso JQ. Oral antibiotic therapy for acne vulgaris: pharmacokinetic and pharmacodynamic perspectives. J Clin Aesthet Dermatol. 2011;4(2):40-47.

Del Rosso JQ. Topical and oral antibiotics for acne vulgaris. Semin Cutan Med Surg. 2016;35(2):57-61.

Kircik L. Doxycycline and minocycline for the management of acne: a review of efficacy and safety with emphasis on clinical implications. J Drugs Dermatol. 2010;9(11):1407-1411.

Shapiro LE, Knowles SR, Shear NH. Comparative safety of tetracycline, minocycline, and doxycycline. Arch Dermatol. 1997;133(10):1224-1130.

Del Rosso JQ. Oral antibiotics. In: Shalita AR, Del Rosso JQ, Webster GF, Eds, Acne Vulgaris, Informa Healthcare, London, United Kingdom, 2011, pp 113-124.

Somech, Arav-Boger R. Assia A, et al. Complications of minocycline therapy for acne vulgaris: case reports and review of the literature. Pediatr Dermatol. 1999;16(6):469-472.

Knowles SR, Shapiro L, Shear NH. Serious adverse reactions induced by minocycline. report of 13 patients and review of the literature. Arch Dermatol. 1996;132(8):934-939.

Garner SE, Eady EA, Bennett C. Minocycline for acne vulgaris: efficacy and safety.
Cochrane Database Syst Rev. 2012 Aug 15;(8):CD002086. doi: 10.1002/14651858.

Teitelbaum JE, Perez-Atayde AR, Cohen M, et al. Minocycline-related autoimmune hepatitis: case series and literature review. Arch Pediatr Adolesc Med. 1998;152(11):1132-1136.

Knowles SR, Shear NH. Cutaneous drug reactions with systemic features. In: Wolverton SE, Ed, Comprehensive Dermatologic Drug Therapy, 3rd Edition, Elsevier-Saunders, Philadelphia, Pennsylvania, 2013, pp 747-752.

Fleming P, Marik PE. The DRESS syndrome: the great clinical mimicker. Pharmacotherapy. 2011;31(3):332.

Oelze LL1, Pillow MT. Phenytoin-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report from the emergency department. J Emerg Med. 2013 Jan;44(1):75-78.

Ramakrishna J, Johnson AR, Banner BF. Long-term minocycline use for acne in healthy adolescents can cause severe autoimmune hepatitis. J Clin Gastroenterol. 2009;43(8):787-790.

Margolis DJ, Hoffstad O, Bilker W. Association or lack of association between tetracycline class antibiotics used for acne vulgaris and lupus erythematosus.
Br J Dermatol. 2007;157(3):540-546.

Friedman DI. Medication-induced intracranial hypertension in dermatology. Am J Clin Dermatol. 2005;6(1):29-37.

Passi SF, Butcher R, Warner JEA, et al. Incidence of idiopathic intracranial hypertension (IIH) among users on tetracycline antibiotics. San Diego CA: North American Neuro-Ophthalmology Society Meeting; February 21-26, 2015.

Chiu AM, Chuenkongkaew WL, Cornblath WT, et al. Minocycline treatment and pseudotumor cerebri. Am J Ophthalmol. 1998;126(1):116-121.

Bababeygy SR, Repka MX, Subramanian PS. Minocycline-associated pseudotumor cerebri with severe papilledema. J Ophthalmol. 2009;2009:203583.

Mochizuki K, Takahashi T, Kano M, et al. Pseudotumor cerebri induced by minocycline for acne vulgaris. Jpn J Ophthalmol. 2002;46(6):668-672.

Most read articles by the same author(s)

1 2 > >>